Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 0.7462
March 31, 2026 0.4552
December 31, 2025 0.3406
September 30, 2025 0.2078
June 30, 2025 0.2119
March 31, 2025 0.1946
December 31, 2024 0.5248
September 30, 2024 0.00
June 30, 2024 -0.8594
March 31, 2024 -0.5023
December 31, 2023 0.1817
September 30, 2023 -0.5648
June 30, 2023 -0.5435
March 31, 2023 -1.042
December 31, 2022 0.00
September 30, 2022 0.00
June 30, 2022 0.00
March 31, 2022 0.00
December 31, 2021 0.00
September 30, 2021 0.00
June 30, 2021 0.00
March 31, 2021
December 31, 2020 0.00
September 30, 2020 0.00
June 30, 2020 0.00
Date Value
March 31, 2020 0.00
December 31, 2019 0.00
September 30, 2019 0.00
June 30, 2019 0.00
March 31, 2019 0.0498
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 0.0646
March 31, 2018 -0.45
December 31, 2017 -0.6518
September 30, 2017 0.00
June 30, 2017 0.00
March 31, 2017 0.8748
December 31, 2016 0.00
September 30, 2016 -0.276
June 30, 2016 -0.4841
March 31, 2016 1.255
December 31, 2015 0.2599
September 30, 2015 0.1187
June 30, 2015 0.0898
March 31, 2015 0.2851
December 31, 2014 0.1487
September 30, 2014 14.39
June 30, 2014 1.402
March 31, 2014 -0.8279

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 1.022
Corcept Therapeutics, Inc. 0.0133
Veru, Inc. 0.0945
Johnson & Johnson 0.5477
Eli Lilly & Co. 1.621

Debt to Equity Ratio Related Metrics